| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Silvia Oggero | |
| Lucy Victoria Norling | |||
| Shani Austin-Williams | |||
| P2860 | cites work | Detection of microRNA expression in human peripheral blood microvesicles | Q21144210 |
| Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences | Q21147057 | ||
| Calcium-dependent phospholipid scrambling by TMEM16F | Q24308774 | ||
| Exosomes with immune modulatory features are present in human breast milk | Q24321270 | ||
| Syndecan-syntenin-ALIX regulates the biogenesis of exosomes | Q24337195 | ||
| MicroRNAs in NF-kappaB signaling | Q24630097 | ||
| The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton | Q24648481 | ||
| Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin | Q24795283 | ||
| Multifaceted Roles of ALG-2 in Ca(2+)-Regulated Membrane Trafficking | Q26738429 | ||
| Resolution of Inflammation: What Controls Its Onset? | Q26747410 | ||
| Classification, functions, and clinical relevance of extracellular vesicles | Q27013032 | ||
| On the origin of microparticles: From "platelet dust" to mediators of intercellular communication | Q27023547 | ||
| Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes | Q27317206 | ||
| Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22 | Q27322292 | ||
| The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase | Q28117594 | ||
| Double-stranded DNA in exosomes: a novel biomarker in cancer detection | Q28237711 | ||
| The resolution of inflammation: Principles and challenges | Q28261128 | ||
| Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury | Q28272621 | ||
| Apoptosis: a review of programmed cell death | Q28305845 | ||
| Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis | Q28509382 | ||
| Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs | Q28750201 | ||
| Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho | Q29614250 | ||
| The mechanisms of vesicle budding and fusion | Q29615234 | ||
| Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes | Q29619437 | ||
| Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis | Q30663963 | ||
| High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells | Q31013634 | ||
| Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential | Q31115948 | ||
| Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis | Q33236178 | ||
| Management of adult idiopathic thrombocytopenic purpura | Q33364595 | ||
| Evidence that platelet-derived microvesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD34+ hematopoietic stem/ progenitor cells--implication for the pathogenesis of immune thrombocytopenias | Q33374641 | ||
| Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles | Q44791838 | ||
| Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis | Q44948880 | ||
| Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. | Q45932171 | ||
| Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. | Q46017959 | ||
| Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes | Q46063754 | ||
| Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production | Q46083601 | ||
| Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients | Q46167362 | ||
| Monocyte-Derived Procoagulant Microvesicles Induced by High Glucose Can Be Attenuated by the Antioxidant N-Acetyl-L-Cysteine, Partly Through the P38/MAPK Pathway | Q46263977 | ||
| Cell-derived microparticles contain caspase 3 in vitro and in vivo | Q46470673 | ||
| Elevation of circulating endothelial microparticles in patients with chronic renal failure. | Q46888760 | ||
| Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease | Q46909923 | ||
| Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro. | Q47109033 | ||
| Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes | Q47835134 | ||
| Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration | Q47838522 | ||
| Platelet-derived miR-142-3p induces apoptosis of endothelial cells in hypertension | Q47856919 | ||
| Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury | Q48562922 | ||
| Plasma exosomes protect the myocardium from ischemia-reperfusion injury. | Q48674766 | ||
| Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility. | Q49960782 | ||
| Neutrophil Microvesicles from Healthy Control and Rheumatoid Arthritis Patients Prevent the Inflammatory Activation of Macrophages | Q49961716 | ||
| Shedding light on the cell biology of extracellular vesicles | Q50018560 | ||
| Anoctamins/TMEM16 Proteins: Chloride Channels Flirting with Lipids and Extracellular Vesicles | Q50057538 | ||
| The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. | Q50191909 | ||
| Microvesicles in vascular homeostasis and diseases. Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology | Q50205919 | ||
| Quantitative phosphoproteomic analysis of IL-33-mediated signaling | Q38421390 | ||
| Platelets and their microparticles as key players in pathophysiological responses | Q38543319 | ||
| Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles | Q38632361 | ||
| Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. | Q38674677 | ||
| PIKfyve inhibition increases exosome release and induces secretory autophagy | Q38756823 | ||
| Activity of Tissue Factor in Microparticles Produced in vitro by Endothelial Cells, Monocytes, Granulocytes, and Platelets | Q38766683 | ||
| Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment | Q38813934 | ||
| Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit | Q38816544 | ||
| Mesenchymal stem cells secrete immunologically active exosomes | Q39039982 | ||
| Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling | Q39063417 | ||
| Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection | Q39200565 | ||
| Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease | Q39452734 | ||
| Prospective study on circulating MicroRNAs and risk of myocardial infarction | Q39583273 | ||
| Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells | Q39628120 | ||
| Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. | Q39673371 | ||
| The pathogenesis of atherosclerosis--an update | Q39726917 | ||
| Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer | Q39781488 | ||
| Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. | Q39812809 | ||
| Multivesicular endosome biogenesis in the absence of ESCRTs | Q39843842 | ||
| Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis | Q39985299 | ||
| Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways | Q40043141 | ||
| Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro | Q40112496 | ||
| Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease | Q40422877 | ||
| Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium | Q40423150 | ||
| Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer | Q40500955 | ||
| Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes | Q40536806 | ||
| Endothelial and platelet microparticles in vasculitis of the young. | Q40538261 | ||
| Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis | Q40646486 | ||
| Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-κB in endothelial cells | Q40659069 | ||
| Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity | Q40732139 | ||
| Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis | Q40837696 | ||
| In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. | Q40851071 | ||
| Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway | Q40969063 | ||
| Immune activated monocyte exosomes alter microRNAs in brain endothelial cells and initiate an inflammatory response through the TLR4/MyD88 pathway | Q41564855 | ||
| SNAREs and NSF in targeted membrane fusion | Q41566661 | ||
| Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production | Q41851230 | ||
| Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction | Q41954783 | ||
| Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen | Q41975625 | ||
| Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands | Q42008613 | ||
| Extravasating Neutrophil-derived Microparticles Preserve Vascular Barrier Function in Inflamed Tissue | Q42080820 | ||
| Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. | Q42165232 | ||
| Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease | Q42581726 | ||
| Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. | Q42773654 | ||
| Microparticles in endothelial cell and vascular homeostasis: are they really noxious? | Q43171552 | ||
| Platelet activation in essential hypertension: implications for antiplatelet treatment | Q43186392 | ||
| MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. | Q43645305 | ||
| Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions | Q43852813 | ||
| Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils | Q44410424 | ||
| Circulating microparticles from patients with septic shock exert protective role in vascular function. | Q44423777 | ||
| Platelet microparticles induce angiogenesis in vitro | Q44724662 | ||
| Outcomes after acute ischemic stroke in patients with thrombocytopenia or thrombocytosis | Q33430508 | ||
| Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. | Q33506630 | ||
| Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. | Q33941102 | ||
| Existence of a microRNA pathway in anucleate platelets | Q34025954 | ||
| A good practice guide to the administration of substances and removal of blood, including routes and volumes | Q34141695 | ||
| Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life | Q34260635 | ||
| Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators | Q34294883 | ||
| HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells | Q34307544 | ||
| Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3. | Q34398929 | ||
| Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model | Q34406142 | ||
| Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology. | Q34485522 | ||
| Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease | Q34489050 | ||
| Endometrial exosomes/microvesicles in the uterine microenvironment: a new paradigm for embryo-endometrial cross talk at implantation | Q34629669 | ||
| Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation | Q34660102 | ||
| Sonic hedgehog carried by microparticles corrects angiotensin II-induced hypertension and endothelial dysfunction in mice | Q34974125 | ||
| Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells | Q34995017 | ||
| Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles | Q35001472 | ||
| Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling | Q35005587 | ||
| Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes | Q35089453 | ||
| MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease | Q35114995 | ||
| Microparticles in hemostasis and thrombosis. | Q35131040 | ||
| Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing | Q35132356 | ||
| Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner | Q35182740 | ||
| Biological properties of extracellular vesicles and their physiological functions. | Q35611763 | ||
| Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs | Q35634914 | ||
| Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles | Q35720825 | ||
| Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. | Q35748408 | ||
| Microparticles: major transport vehicles for distinct microRNAs in circulation | Q35792749 | ||
| Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA | Q35845952 | ||
| Mononuclear Phagocyte-Derived Microparticulate Caspase-1 Induces Pulmonary Vascular Endothelial Cell Injury | Q35879582 | ||
| Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis | Q36035220 | ||
| Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction | Q36040528 | ||
| Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism | Q36057489 | ||
| Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression | Q36067866 | ||
| Endothelial Microparticle–Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles | Q61851521 | ||
| Ability of Platelet-Derived Extracellular Vesicles to Promote Neutrophil-Endothelial Cell Interactions | Q63408293 | ||
| Identification of an activated neutrophil phenotype in polymyalgia rheumatica during steroid treatment: a potential involvement of immune cell cross-talk | Q64075684 | ||
| Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration | Q64273125 | ||
| MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner | Q64377029 | ||
| Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis | Q64378678 | ||
| Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus | Q71781373 | ||
| Protein synthesis by human platelets | Q72215502 | ||
| Ectosomes released by human neutrophils are specialized functional units | Q73050613 | ||
| Induction of relA(p65) and I kappa B alpha subunit expression during differentiation of human peripheral blood monocytes to macrophages | Q73217980 | ||
| Leukocyte-leukocyte interactions mediated by platelet microparticles under flow | Q73426888 | ||
| Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses | Q73774768 | ||
| Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells | Q77408980 | ||
| Endothelial cell activation by leukocyte microparticles | Q77437049 | ||
| Effects of severe hypertension on endothelial and platelet microparticles | Q78945402 | ||
| Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects | Q79234231 | ||
| Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells | Q79804242 | ||
| Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism | Q81445961 | ||
| Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles | Q81561860 | ||
| Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization | Q81723006 | ||
| D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study | Q82256250 | ||
| Circulating procoagulant microparticles in obesity | Q82757597 | ||
| Endothelial injury and repair in systemic vasculitis of the young | Q83006888 | ||
| Endothelium-derived microparticles inhibit angiogenesis in the heart and enhance the inhibitory effects of hypercholesterolemia on angiogenesis | Q83231659 | ||
| Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation | Q83393028 | ||
| Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function | Q84096693 | ||
| Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus | Q84393427 | ||
| Involvement of microparticles in diabetic vascular complications | Q84465761 | ||
| Exosomes Derived from Immature Bone Marrow Dendritic Cells Induce Tolerogenicity of Intestinal Transplantation in Rats | Q85006087 | ||
| Ectosomes released by platelets induce differentiation of CD4+T cells into T regulatory cells | Q85290797 | ||
| Angiotensin II induces the generation of procoagulant microparticles by human mononuclear cells via an angiotensin type 2 receptor-mediated pathway | Q86132245 | ||
| Functionally and morphologically distinct populations of extracellular vesicles produced by human neutrophilic granulocytes | Q87330519 | ||
| Cholesterol and the journey of extracellular vesicles | Q88426782 | ||
| Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells | Q88483632 | ||
| Neutrophil-Derived Exosomes: A New Mechanism Contributing to Airway Smooth Muscle Remodeling | Q89278867 | ||
| Studying the Fate of Tumor Extracellular Vesicles at High Spatiotemporal Resolution Using the Zebrafish Embryo | Q91466131 | ||
| Protein Composition Reflects Extracellular Vesicle Heterogeneity | Q91823615 | ||
| Exosomes derived from monocytes and from endothelial cells mediate monocyte and endothelial cell activation under high d-glucose conditions | Q92084024 | ||
| Reassessment of Exosome Composition | Q92878002 | ||
| IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets. | Q50656675 | ||
| Up-Regulated Expression of Matrix Metalloproteinases in Endothelial Cells Mediates Platelet Microvesicle-Induced Angiogenesis. | Q50682555 | ||
| Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events. | Q50715544 | ||
| Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6. | Q51159605 | ||
| Metabolic and Signaling Functions of Cancer Cell-Derived Extracellular Vesicles. | Q51544548 | ||
| Platelet-mediated activation of endothelial cells: implications for the pathogenesis of transplant rejection. | Q52543661 | ||
| Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142-3p. | Q52685155 | ||
| Differential procoagulant activity of microparticles derived from monocytes, granulocytes, platelets and endothelial cells: impact of active tissue factor. | Q52785204 | ||
| Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. | Q52927674 | ||
| Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. | Q53208395 | ||
| Platelet microparticles reprogram macrophage gene expression and function. | Q53358769 | ||
| Plasma markers of endothelial dysfunction in patients with hypertensive disorders of pregnancy: a pilot study in a South Indian population. | Q53363860 | ||
| Diagnostic role of endothelial microparticles in vasculitis. | Q53446731 | ||
| Circulating endothelial microparticles as a marker of cerebrovascular disease. | Q53497260 | ||
| MicroRNAs in Cardiovascular Disease. | Q53641839 | ||
| Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. | Q53659688 | ||
| Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection. | Q53713471 | ||
| Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis. | Q54504167 | ||
| Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. | Q55057015 | ||
| Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning | Q58116122 | ||
| CD3+/CD45+ and SMA-α+ circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event | Q58419413 | ||
| Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction | Q58584810 | ||
| Extracellular Vesicles Work as a Functional Inflammatory Mediator Between Vascular Endothelial Cells and Immune Cells | Q58798796 | ||
| LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy. Findings from the METEOR trial | Q58824546 | ||
| Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease | Q59134251 | ||
| Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques | Q60651924 | ||
| LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b | Q36073902 | ||
| Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles | Q36121826 | ||
| Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms | Q36220355 | ||
| Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. | Q36223338 | ||
| MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages | Q36357815 | ||
| Antibacterial effect of microvesicles released from human neutrophilic granulocytes | Q36542831 | ||
| Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. | Q36580760 | ||
| Procoagulant microparticles: disrupting the vascular homeostasis equation? | Q36600785 | ||
| RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. | Q36713922 | ||
| MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy | Q36802746 | ||
| Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer | Q36888926 | ||
| The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles | Q36898211 | ||
| Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. | Q37066520 | ||
| Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties | Q37072869 | ||
| Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease | Q37073587 | ||
| Lactadherin and clearance of platelet-derived microvesicles | Q37086945 | ||
| Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects | Q37112875 | ||
| Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor | Q37151134 | ||
| Effects of ceramide and other simple sphingolipids on membrane lateral structure | Q37291700 | ||
| Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats | Q37298327 | ||
| Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles | Q37366431 | ||
| Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena | Q37545031 | ||
| Low MT-CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease | Q37556409 | ||
| Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis | Q37629798 | ||
| Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion. | Q37672715 | ||
| Clinical relevance of microparticles from platelets and megakaryocytes | Q37782534 | ||
| Platelet- and megakaryocyte-derived microparticles | Q37806997 | ||
| The many faces of endothelial microparticles. | Q37821169 | ||
| Exosomes: small vesicles participating in intercellular communication | Q37949103 | ||
| Extracellular vesicles: biology and emerging therapeutic opportunities. | Q38098874 | ||
| Tetraspanins at a glance. | Q38240344 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | extracellular vesicle | Q21097485 |
| P304 | page(s) | 1479 | |
| P577 | publication date | 2019-12-17 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue Repair | |
| P478 | volume | 10 |
| Q96304607 | Extracellular Vesicles as Potential Prognostic Markers of Lymphatic Dysfunction | cites work | P2860 |
Search more.